Ucb SA
F:UNC0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
U
|
Ucb SA
F:UNC0
|
BE |
|
ValueCommerce Co Ltd
OTC:VCCLF
|
JP |
|
A
|
Arecor Therapeutics PLC
F:6UI
|
UK |
|
Nan Hai Corporation Ltd
F:SO7
|
HK |
|
Guardion Health Sciences Inc
F:0QTA
|
US |
|
CellaVision AB
OTC:CLVSF
|
SE |
Wall St Price Targets
UNC0 Price Targets Summary
Ucb SA
According to Wall Street analysts, the average 1-year price target for UNC0 is 144.21 EUR with a low forecast of 110.15 EUR and a high forecast of 176.97 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is UNC0's stock price target?
Price Target
144.21
EUR
According to Wall Street analysts, the average 1-year price target for UNC0 is 144.21 EUR with a low forecast of 110.15 EUR and a high forecast of 176.97 EUR.
What is the Revenue forecast for Ucb SA?
Projected CAGR
9%
Over the last 14 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 8 years is 9%.
What is the Gross Profit forecast for Ucb SA?
Projected CAGR
10%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 7%. The projected CAGR for the next 8 years is 10%.
What is the Operating Income forecast for Ucb SA?
Projected CAGR
19%
Over the last 14 years, the compound annual growth rate for Operating Income has been 12%. The projected CAGR for the next 8 years is 19%.
What is the Pre-Tax Income forecast for Ucb SA?
Projected CAGR
27%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 16%. The projected CAGR for the next 3 years is 27%.
What is the Net Income forecast for Ucb SA?
Projected CAGR
18%
Over the last 14 years, the compound annual growth rate for Net Income has been 14%. The projected CAGR for the next 8 years is 18%.
